Melhem Solh, MD

Dr. Melhem Solh graduated from the American University of Beirut, Lebanon in 1999 with a BS in Chemistry.  He received his MD from the same institution in 2003.  He performed his residency in Internal Medicine at Wayne State University/Detroit Medical Center.  He simultaneously pursued a PhD in Cancer Biology.  During this time he was the principal investigator in a clinical retrospective trial to investigate whether statins affect the expression of estrogen/progesterone receptors in breast cancer patients (under the supervision of Dr. Mohammad Siddique) and the principal investigator on a clinical research study concerning the outcome of synchronous and metachronous breast cancer (under the supervision of Dr. Marc Feldman).  Dr. Solh entered the Hematology, Oncology and Transplantation fellowship program at the University of Minnesota in 2008.

Selected Publications/Presentations

Solh M, Abbas J, Khalifeh M.  Gemzar treatment improves surgical outcome in advanced disease.  American University of Beirut Research Day, 2003.

Solh M, Danquah G, Kolachalam R.  Internet use and its effect on the patient-physician relationship. American College of Surgeons National Conference, 2005.

Solh M, Dubay L, Lobocki C, Mitall V.  Hypercalcemia and vitamin D3 analogues in treatment of breast cancer.  American College of Surgeons National Conference, 2005.

Solh M, Bu H, Li A, Mittal V.  Outcome and Staging in Metachronous Breast Disease.  Wayne State University/Detroit Medical Center Research Day, 2006.

Solh M, Ali H, Mittal V.  Synchronous and metachronous breast cancer: Characteristics of the second tumor.  American College of Physicians/Michigan Chapter, 2006.

Solh M.  Seocalcitol and vitamin D3 as modulators of cell growth in breast cancer cell lines.  American College of Physicians/Michigan Chapter, 2006.